Irbesartan in patients with atrial fibrillation

S Yusuf, JS Healey, J Pogue, S Chrolavicius, M Flather, RG Hart, SH Hohnloser, CD Joyner, MA Pfeffer, SJ Connolly

Research output: Contribution to journalArticlepeer-review

200 Citations (Scopus)


Irbesartan did not reduce cardiovascular events in patients with atrial fibrillation. (Funded by Bristol-Myers Squibb and Sanofi-Aventis; number, NCT00249795.).
Original languageEnglish
Pages (from-to)928-938
Number of pages11
JournalNew England Journal of Medicine
Issue number10
Publication statusPublished - 2011

Cite this